Bio-Techne Corp
NASDAQ:TECH

  • LAST PRICE
    78.3000
  • TODAY'S CHANGE (%)
    -2.0600 (-2.5635%)
  • Bid / Lots
    76.6800/ 1
  • Ask / Lots
    80.1900/ 1
  • Open / Previous Close
    79.7300 / 80.3600
  • Day Range
    77.3800
    79.9900
  • 52 Week Range
    51.7900
    85.5700
  • Volume
    1,558,282

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Sep 18, 2024

      Show headlines and story abstract

    • 7:00AM ET on Wednesday Sep 18, 2024 by PR Newswire
      Companies Mentioned: TECH

      ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that ImmunoScape Pte. Ltd. (a Singapore-U.S. based TCR-T therapy company) has been awarded a G-Rex(R) Grant. ImmunoScape's $250,000 G-Rex(R) Grant will enable process development and IND enabling studies of their novel WT1-targeted TCR-T cell therapy.

    • 7:00AM ET on Wednesday Sep 18, 2024 by PR Newswire
      Companies Mentioned: TECH

      Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environmental, Social and Governance (ESG) initiatives. Bio-Techne's CSR is organized around four key pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment. Bio-Techne's EPIC values (Empowerment, Passion, Innovation and Collaboration) remain the backbone of our corporate culture and provide the foundation for our approach to continuously improving our corporate sustainability. The updated CSR is available in the Corporate and Social Responsibility section of Bio-Techne's website.

    • 7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
      Companies Mentioned: TECH

      ScaleReady announces a G-Rex(R) Grant has been awarded to ImmunoScape

      PR Newswire

      ST. PAUL, Minn., Sept. 18, 2024

      ST. PAUL, Minn., Sept. 18, 2024 /PRNewswire/ -- ScaleReady(TM), in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady(TM), today announced that ImmunoScape Pte. Ltd. (a Singapore-U.S. based TCR-T therapy company) has been awarded a G-Rex(R) Grant. ImmunoScape's $250,000 G-Rex(R) Grant will enable process development and IND enabling studies of their novel WT1-targeted TCR-T cell therapy.

    • 7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
      Companies Mentioned: TECH

      BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT

      PR Newswire

      MINNEAPOLIS, Sept. 18, 2024

      MINNEAPOLIS, Sept. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environmental, Social and Governance (ESG) initiatives. Bio-Techne's CSR is organized around four key pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment. Bio-Techne's EPIC values (Empowerment, Passion, Innovation and Collaboration) remain the backbone of our corporate culture and provide the foundation for our approach to continuously improving our corporate sustainability. The updated CSR is available in the Corporate and Social Responsibility section of Bio-Techne's website.

  • Sep 17, 2024

Peers Headlines